Sukhvir S Atwal, MD
Nephrology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 27 years
- Graduated 1999
Offices
1 location · The Nephrology Group Inc · 50 clinicians in this group
Looking this up.
Hospitals listed: 052612 · 552702 · 552729 · 552820 · 552865 · Clovis Community Medical Center · Community Regional Medical Center · Saint Agnes Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Atwal’s office at (559) 228-9660 to ask if they take your plan before you enroll.
California Medical Board record
Licence A96047 · Current
Licensed to practise in California · since 2006 · expires 2028-02-29 · Punjab University, Government Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Fresno Ambulatory Surgery Center, Inc.Ambulatory Surgery Center · Fresno, CA9.09% owner since 2016 · accredited by AAAHCAccreditation Renewed2 inspections, 1 with deficiencies · last 2021-10-27: Requirements Met
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
- Saint Agnes Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.312, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Saint Agnes Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.312 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.141 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.18 to 1.94) · 2,342 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 197.82 (152.64 to 243.01) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 300 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 768 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.8 · 969 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,305 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,641 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 12,213 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.76 (2.91 to 6.61) · 2,466 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.09 (0 to 2.49) · 864 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.61 (0.26 to 2.96) · 2,362 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.1 (5.39 to 14.81) · 900 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.4 (1.2 to 7.59) · 882 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.84 (0.41 to 3.27) · 541 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.67 (0.14 to 1.19) · 9,626 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 58 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.835 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.182 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.004 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 412 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 1,002 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 28.8 · 296 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.5 · 894 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.8 · 981 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 1,061 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.4 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 412 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.6 to 15.9) · 1,324 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 863 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 32% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$391,521
Medicare paid this office $391,521 for 880 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 96 | $158,076 | $278 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 253 | $54,071 | $62 |
| Return visit (30+ min) | 403 | $46,660 | $70 |
| Parathormone (parathyroid hormone) level | 209 | $13,922 | $40 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 65 | $13,874 | None |
See all 37 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 96 | $158,076 | $278 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 253 | $54,071 | $62 |
| Return visit (30+ min) | 403 | $46,660 | $70 |
| Parathormone (parathyroid hormone) level | 209 | $13,922 | $40 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 65 | $13,874 | None |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 40 | $13,237 | $228 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $9,283 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $8,498 | $93 |
| Long return visit (40+ min) | 60 | $6,594 | $82 |
| Cystatin c (enzyme inhibitor) level | 215 | $6,018 | $18 |
| Insertion of needle into vein for collection of blood sample | 298 | $5,266 | $9 |
| New patient visit (45+ min) | 40 | $5,075 | $127 |
| Hemodialysis procedure with physician evaluation | 59 | $5,030 | $56 |
| Blood test, comprehensive group of blood chemicals | 253 | $4,834 | $10 |
| Magnesium level | 250 | $3,054 | $7 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 222 | $2,773 | $8 |
| Urine microalbumin (protein) level | 266 | $2,665 | $6 |
| Creatinine level to test for kidney function or muscle injury | 276 | $2,468 | $5 |
| Dialysis procedure including 1 evaluation | 12 | $2,189 | $68 |
| Phosphate level | 251 | $2,162 | $5 |
| Total protein level, urine | 276 | $1,745 | $4 |
| Vitamin d-3 level | 44 | $1,276 | $29 |
| Injection of drug or substance under skin or into muscle | 65 | $1,053 | $11 |
| Limited ultrasound scan behind abdominal cavity | 21 | $946 | $43 |
| Folic acid level, serum | 41 | $836 | $14 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $817 | $39 |
| Cyanocobalamin (vitamin b-12) level | 40 | $813 | $15 |
| Red blood count automated, with additional calculations | 95 | $623 | $5 |
| Kidney function blood test panel | 66 | $579 | $9 |
| Iron binding capacity | 43 | $514 | $9 |
| Ferritin (blood protein) level | 20 | $441 | $13 |
| Hemoglobin a1c level | 37 | $401 | $9 |
| Iron level | 43 | $380 | $6 |
| Blood test, lipids (cholesterol and triglycerides) | 24 | $313 | $13 |
| Red blood cell concentration measurement | 14 | $158 | $2 |
| Blood count, hemoglobin | 14 | $158 | $2 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 17 | $114 | $6 |
Who their Medicare patients are
880 Original Medicare patients in 2024. Average age 73 · Under 65 18% · 85 and older 15% · Women 49% · Also on Medicaid 53% · Health risk score 4.28. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 69% · Coronary heart disease 53% · Heart failure 48% · Atrial fibrillation 30% · Depression 25% · COPD 24% · Cancer 15% · Dementia 14% · Stroke 12%.
The office billed $1,544,027, Medicare allowed $496,523 and paid $391,521; for 13,849 services of 72 kinds; $14,855 of it was for drugs given in the office and $376,666 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 880 | 13,849 | 73 | 4.28 | $1,544,027 | $391,521 |
| 2023 | 961 | 15,466 | 72 | 3.82 | $1,546,869 | $391,921 |
| 2022 | 1,007 | 11,043 | 72 | 3.86 | $1,534,164 | $407,425 |
| 2021 | 1,056 | 8,662 | 71 | 4.01 | $1,335,306 | $399,311 |
| 2020 | 1,099 | 11,120 | 71 | 4.75 | $954,401 | $379,834 |
| 2019 | 1,088 | 14,716 | 72 | 4.17 | $896,066 | $438,250 |
| 2018 | 1,094 | 11,860 | 71 | 4.34 | $829,465 | $437,753 |
| 2017 | 1,080 | 11,928 | 71 | 4.36 | $795,150 | $466,315 |
| 2016 | 1,084 | 8,790 | 70 | 4.46 | $777,995 | $429,222 |
| 2015 | 1,102 | 8,060 | 70 | 4.23 | $794,592 | $437,854 |
| 2014 | 1,168 | 7,185 | 71 | 4.20 | $781,376 | $439,257 |
| 2013 | 1,141 | 7,024 | 70 | 4.29 | $795,546 | $450,648 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 37 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 93 | $146,954 | $278 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 258 | $51,369 | $63 |
| Return visit (30+ min) | 400 | $46,219 | $70 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 122 | $31,439 | None |
| Parathormone (parathyroid hormone) level | 228 | $13,812 | $40 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 34 | $10,231 | $227 |
| Cystatin c (enzyme inhibitor) level | 265 | $8,161 | $18 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $5,943 | $138 |
| New patient visit (45+ min) | 49 | $5,386 | $110 |
| Insertion of needle into vein for collection of blood sample | 306 | $5,102 | $8 |
| Long return visit (40+ min) | 43 | $3,936 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $3,698 | $95 |
| Hemodialysis procedure with physician evaluation | 49 | $3,697 | $57 |
| Vitamin d-3 level | 107 | $3,404 | $29 |
| Complete ultrasound scan behind abdominal cavity | 40 | $3,241 | $81 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 254 | $3,177 | $8 |
| Kidney function blood test panel | 242 | $3,001 | $8 |
| Injection of drug or substance under skin or into muscle | 128 | $2,576 | $11 |
| Urine microalbumin (protein) level | 263 | $2,506 | $6 |
| Creatinine level to test for kidney function or muscle injury | 281 | $2,447 | $5 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 41 | $2,435 | $39 |
| Red blood count automated, with additional calculations | 239 | $2,230 | $5 |
| Blood test, comprehensive group of blood chemicals | 131 | $1,709 | $10 |
| Total protein level, urine | 276 | $1,684 | $4 |
| Ferritin (blood protein) level | 85 | $1,510 | $13 |
| Magnesium level | 131 | $1,105 | $7 |
| Phosphate level | 130 | $768 | $5 |
| Cyanocobalamin (vitamin b-12) level | 32 | $739 | $15 |
| Folic acid level, serum | 20 | $519 | $14 |
| Acute hepatitis panel | 11 | $513 | $47 |
| Iron binding capacity | 20 | $301 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 37 | $241 | $6 |
| Iron level | 20 | $223 | $6 |
| Blood test, lipids (cholesterol and triglycerides) | 12 | $157 | $13 |
| Red blood cell concentration measurement | 20 | $153 | $2 |
| Blood count, hemoglobin | 20 | $153 | $2 |
| Hemoglobin a1c level | 12 | $124 | $10 |
2022: 37 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 99 | $157,503 | $288 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 297 | $50,966 | $57 |
| Return visit (30+ min) | 294 | $41,394 | $100 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 88 | $25,375 | $225 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 91 | $23,044 | None |
| Parathormone (parathyroid hormone) level | 219 | $14,662 | $41 |
| Telephone medical discussion with physician, 11-20 minutes | 178 | $7,967 | $41 |
| New patient visit (45+ min) | 60 | $7,556 | $126 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $7,456 | $155 |
| Cystatin c (enzyme inhibitor) level | 223 | $6,245 | $18 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 99 | $5,850 | $31 |
| Complete ultrasound scan behind abdominal cavity | 51 | $4,351 | $85 |
| Vitamin d-3 level | 125 | $4,218 | $29 |
| Hemodialysis procedure with physician evaluation | 48 | $3,657 | $58 |
| Dialysis services, 1 physician visit per month (20 years or older) | 17 | $3,344 | $167 |
| Kidney function blood test panel | 240 | $3,086 | $9 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 228 | $3,003 | $8 |
| Red blood count automated, with additional calculations | 226 | $2,137 | $5 |
| Urine microalbumin (protein) level | 227 | $2,092 | $6 |
| Injection of drug or substance under skin or into muscle | 98 | $2,034 | $11 |
| Creatinine level to test for kidney function or muscle injury | 241 | $1,989 | $5 |
| Dialysis procedure including 1 evaluation | 13 | $1,613 | $70 |
| Total protein level, urine | 238 | $1,398 | $4 |
| Insertion of needle into vein for collection of blood sample | 253 | $1,331 | $3 |
| Ferritin (blood protein) level | 67 | $1,207 | $13 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $921 | $54 |
| Cyanocobalamin (vitamin b-12) level | 37 | $743 | $15 |
| Blood test, comprehensive group of blood chemicals | 64 | $727 | $10 |
| Short return visit (20+ min) | 13 | $653 | $50 |
| Folic acid level, serum | 32 | $652 | $14 |
| Magnesium level | 78 | $588 | $7 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 11 | $543 | $34 |
| Iron binding capacity | 32 | $388 | $9 |
| Blood test, lipids (cholesterol and triglycerides) | 28 | $370 | $13 |
| Phosphate level | 65 | $331 | $5 |
| Iron level | 32 | $287 | $6 |
| Hemoglobin a1c level | 18 | $182 | $10 |
2021: 38 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 118 | $138,849 | $289 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 179 | $66,903 | $240 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 234 | $43,144 | $58 |
| Telephone medical discussion with physician, 11-20 minutes | 369 | $38,735 | $67 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 77 | $17,024 | None |
| Dialysis services, 1 physician visit per month (20 years or older) | 60 | $12,987 | $166 |
| Parathormone (parathyroid hormone) level | 174 | $11,476 | $41 |
| New patient visit (45+ min) | 65 | $8,207 | $126 |
| Cystatin c (enzyme inhibitor) level | 192 | $5,334 | $19 |
| Telephone medical discussion with physician, 21-30 minutes | 38 | $3,613 | $95 |
| Complete ultrasound scan behind abdominal cavity | 39 | $3,245 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $2,968 | $156 |
| Kidney function blood test panel | 195 | $2,561 | $9 |
| Hemodialysis procedure with physician evaluation | 36 | $2,447 | $60 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 179 | $2,339 | $8 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 45 | $2,156 | $31 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 21 | $2,007 | $42 |
| Return visit (30+ min) | 19 | $1,906 | $100 |
| Urine microalbumin (protein) level | 194 | $1,711 | $6 |
| Red blood count automated, with additional calculations | 173 | $1,621 | $6 |
| Creatinine level to test for kidney function or muscle injury | 196 | $1,554 | $5 |
| Injection of drug or substance under skin or into muscle | 83 | $1,390 | $12 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 34 | $1,201 | $35 |
| Insertion of needle into vein for collection of blood sample | 206 | $1,062 | $3 |
| Total protein level, urine | 177 | $1,013 | $4 |
| Short return visit (20+ min) | 13 | $905 | $53 |
| Vitamin d-3 level | 19 | $622 | $30 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 25 | $606 | $15 |
| Cyanocobalamin (vitamin b-12) level | 22 | $543 | $15 |
| Folic acid level, serum | 21 | $515 | $15 |
| Ferritin (blood protein) level | 20 | $450 | $14 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 27 | $417 | $15 |
| Blood test, comprehensive group of blood chemicals | 31 | $412 | $11 |
| Iron binding capacity | 19 | $288 | $9 |
| Magnesium level | 33 | $281 | $7 |
| Iron level | 19 | $214 | $6 |
| Phosphate level | 30 | $175 | $5 |
| Blood test, lipids (cholesterol and triglycerides) | 11 | $161 | $13 |
2020: 41 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 140 | $127,908 | $220 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 199 | $58,704 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 299 | $50,559 | $56 |
| Telephone medical discussion with physician, 11-20 minutes | 297 | $23,082 | $57 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 67 | $15,986 | None |
| Parathormone (parathyroid hormone) level | 206 | $13,154 | $41 |
| Home dialysis services per month (20 years or older) | 11 | $12,037 | $177 |
| Return visit (30+ min) | 182 | $11,124 | $57 |
| Dialysis services, 1 physician visit per month (20 years or older) | 69 | $10,538 | $146 |
| Cystatin c (enzyme inhibitor) level | 252 | $7,294 | $18 |
| New patient visit (45+ min) | 47 | $5,767 | $123 |
| Hemodialysis procedure with physician evaluation | 62 | $4,639 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,333 | $159 |
| Kidney function blood test panel | 227 | $2,665 | $9 |
| Complete ultrasound scan behind abdominal cavity | 28 | $2,500 | $89 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 55 | $2,403 | $31 |
| Urine microalbumin (protein) level | 256 | $2,301 | $6 |
| Creatinine level to test for kidney function or muscle injury | 264 | $2,166 | $5 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 191 | $2,096 | $8 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | $1,916 | $77 |
| Insertion of needle into vein for collection of blood sample | 278 | $1,476 | $3 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,452 | $81 |
| Blood test, comprehensive group of blood chemicals | 118 | $1,332 | $10 |
| Vitamin d-3 level | 40 | $1,256 | $29 |
| Injection of drug or substance under skin or into muscle | 68 | $979 | $11 |
| Short return visit (20+ min) | 21 | $859 | $39 |
| Dialysis services, per day, less than full month service (20 years or older) | 29 | $731 | $6 |
| Phosphate level | 123 | $631 | $5 |
| Red blood count automated, with additional calculations | 92 | $614 | $5 |
| Total protein level, urine | 129 | $594 | $4 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 14 | $495 | $35 |
| Folic acid level, serum | 17 | $409 | $15 |
| Magnesium level | 55 | $401 | $7 |
| Cyanocobalamin (vitamin b-12) level | 16 | $375 | $15 |
| Ferritin (blood protein) level | 12 | $311 | $14 |
| Iron binding capacity | 14 | $217 | $9 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 23 | $211 | $9 |
| Iron level | 14 | $161 | $6 |
| Blood test, basic group of blood chemicals (calcium, total) | 16 | $133 | $8 |
| Red blood cell concentration measurement | 15 | $122 | $2 |
| Blood count, hemoglobin | 15 | $122 | $2 |
2019: 36 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 87 | $122,142 | $230 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 396 | $72,180 | $59 |
| Return visit (30+ min) | 425 | $60,828 | $78 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 118 | $59,495 | None |
| Parathormone (parathyroid hormone) level | 250 | $19,364 | $44 |
| Home dialysis services per month (20 years or older) | 12 | $15,954 | $186 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 41 | $11,707 | $192 |
| Hemodialysis procedure with physician evaluation | 105 | $9,125 | $60 |
| Vitamin d-3 level | 228 | $8,650 | $32 |
| Cystatin c (enzyme inhibitor) level | 247 | $7,316 | $18 |
| Complete ultrasound scan behind abdominal cavity | 65 | $5,797 | $88 |
| New patient visit (45+ min) | 37 | $4,609 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $4,360 | $84 |
| Injection of drug or substance under skin or into muscle | 120 | $3,838 | $14 |
| Kidney function blood test panel | 229 | $3,569 | $9 |
| Ultrasound of leg arteries or artery grafts | 14 | $3,158 | $211 |
| Urine microalbumin (protein) level | 293 | $3,118 | $6 |
| Creatinine level to test for kidney function or muscle injury | 295 | $2,858 | $6 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 189 | $2,279 | $8 |
| Insertion of needle into vein for collection of blood sample | 323 | $1,991 | $3 |
| Blood test, basic group of blood chemicals (calcium, total) | 134 | $1,328 | $9 |
| Short return visit (20+ min) | 18 | $989 | $55 |
| Cyanocobalamin (vitamin b-12) level | 38 | $968 | $16 |
| Folic acid level, serum | 38 | $961 | $16 |
| Phosphate level | 125 | $697 | $5 |
| Ferritin (blood protein) level | 22 | $579 | $15 |
| Iron binding capacity | 34 | $514 | $10 |
| Magnesium level | 49 | $417 | $7 |
| Iron level | 34 | $381 | $7 |
| Blood test, comprehensive group of blood chemicals | 29 | $359 | $11 |
| Red blood cell concentration measurement | 67 | $356 | $3 |
| Blood count, hemoglobin | 67 | $356 | $3 |
| Hemoglobin a1c level | 26 | $298 | $10 |
| Blood test, lipids (cholesterol and triglycerides) | 14 | $233 | $15 |
| Total protein level, urine | 38 | $176 | $4 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 22 | $155 | $7 |
2018: 38 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 104 | $141,005 | $226 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 390 | $67,869 | $58 |
| Return visit (30+ min) | 440 | $65,792 | $80 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 89 | $36,021 | None |
| Parathormone (parathyroid hormone) level | 268 | $21,940 | $50 |
| Home dialysis services per month (20 years or older) | 15 | $18,428 | $188 |
| Vitamin d-3 level | 231 | $9,858 | $36 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 40 | $8,980 | $187 |
| Hemodialysis procedure with physician evaluation | 92 | $7,538 | $59 |
| Cystatin c (enzyme inhibitor) level | 225 | $5,118 | $18 |
| Complete ultrasound scan behind abdominal cavity | 55 | $4,911 | $88 |
| New patient visit (45+ min) | 40 | $4,893 | $122 |
| New patient visit (60+ min) | 26 | $4,338 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $3,458 | $84 |
| Urine microalbumin (protein) level | 290 | $3,439 | $7 |
| Creatinine level to test for kidney function or muscle injury | 302 | $3,207 | $6 |
| Blood test, basic group of blood chemicals (calcium, total) | 200 | $3,070 | $10 |
| Kidney function blood test panel | 209 | $2,628 | $11 |
| Injection of drug or substance under skin or into muscle | 90 | $2,490 | $17 |
| Ultrasound of leg arteries or artery grafts | 11 | $2,455 | $223 |
| Insertion of needle into vein for collection of blood sample | 322 | $2,058 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 147 | $1,636 | $9 |
| Phosphate level | 177 | $1,458 | $6 |
| Total protein level, urine | 215 | $1,172 | $4 |
| Cyanocobalamin (vitamin b-12) level | 45 | $1,061 | $18 |
| Folic acid level, serum | 45 | $1,017 | $18 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 98 | $884 | $8 |
| Short return visit (20+ min) | 14 | $600 | $43 |
| Iron binding capacity | 41 | $561 | $10 |
| Blood test, comprehensive group of blood chemicals | 29 | $426 | $13 |
| Iron level | 41 | $416 | $8 |
| Red blood cell concentration measurement | 59 | $391 | $3 |
| Blood count, hemoglobin | 59 | $391 | $3 |
| Hemoglobin a1c level | 31 | $376 | $12 |
| Measurement of complement (immune system proteins), antigen, | 11 | $319 | $15 |
| Blood test, lipids (cholesterol and triglycerides) | 20 | $310 | $16 |
| Magnesium level | 34 | $300 | $8 |
| Ferritin (blood protein) level | 12 | $280 | $16 |
2017: 38 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 122 | $156,635 | $226 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 402 | $72,125 | $58 |
| Return visit (30+ min) | 414 | $59,081 | $77 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 84 | $38,999 | None |
| Parathormone (parathyroid hormone) level | 247 | $21,985 | $55 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 48 | $17,966 | $193 |
| Home dialysis services per month (20 years or older) | 14 | $13,122 | $177 |
| New patient visit (45+ min) | 99 | $10,962 | $111 |
| Vitamin d-3 level | 220 | $10,515 | $40 |
| Hemodialysis procedure with physician evaluation | 112 | $10,366 | $58 |
| Complete ultrasound scan behind abdominal cavity | 74 | $6,966 | $94 |
| Cystatin c (enzyme inhibitor) level | 214 | $5,706 | $18 |
| Kidney function blood test panel | 215 | $3,496 | $12 |
| Creatinine level to test for kidney function or muscle injury | 275 | $3,175 | $7 |
| Urine microalbumin (protein) level | 256 | $3,086 | $8 |
| Injection of drug or substance under skin or into muscle | 85 | $2,854 | $21 |
| Complete ultrasound study of arm and leg arteries | 13 | $2,851 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $2,708 | $85 |
| Dialysis procedure including 1 evaluation | 14 | $2,585 | $70 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 156 | $2,029 | $10 |
| Insertion of needle into vein for collection of blood sample | 283 | $1,656 | $3 |
| Total protein level, urine | 214 | $1,638 | $5 |
| Hemoglobin a1c level | 71 | $1,214 | $13 |
| Blood test, basic group of blood chemicals (calcium, total) | 83 | $1,111 | $11 |
| Magnesium level | 94 | $965 | $9 |
| Short return visit (20+ min) | 14 | $902 | $60 |
| Blood test, comprehensive group of blood chemicals | 84 | $808 | $9 |
| Cyanocobalamin (vitamin b-12) level | 27 | $669 | $20 |
| Folic acid level, serum | 25 | $633 | $20 |
| Phosphate level | 94 | $547 | $5 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 45 | $478 | $9 |
| Blood test, lipids (cholesterol and triglycerides) | 40 | $469 | $11 |
| Blood count, hemoglobin | 80 | $458 | $3 |
| Red blood cell concentration measurement | 80 | $455 | $3 |
| Measurement of complement (immune system proteins), antigen, | 14 | $403 | $16 |
| Iron binding capacity | 26 | $311 | $9 |
| Iron level | 28 | $305 | $9 |
| Ferritin (blood protein) level | 11 | $257 | $18 |
2016: 38 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 117 | $164,524 | $228 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 411 | $77,095 | $58 |
| Return visit (30+ min) | 392 | $54,119 | $75 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 85 | $31,359 | None |
| Hemodialysis procedure with physician evaluation | 141 | $15,224 | $58 |
| New patient visit (45+ min) | 107 | $12,317 | $115 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 35 | $10,235 | $193 |
| Parathormone (parathyroid hormone) level | 99 | $6,457 | $55 |
| Complete ultrasound scan behind abdominal cavity | 63 | $5,815 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,086 | $164 |
| Ultrasound of leg arteries or artery grafts | 21 | $3,267 | $156 |
| Vitamin d-3 level | 80 | $3,247 | $39 |
| Complete ultrasound study of arm and leg arteries | 13 | $3,074 | $118 |
| Dialysis procedure including 1 evaluation | 18 | $2,866 | $64 |
| Injection of drug or substance under skin or into muscle | 86 | $2,451 | $21 |
| Short return visit (20+ min) | 25 | $1,499 | $54 |
| Kidney function blood test panel | 85 | $1,303 | $11 |
| Cystatin c (enzyme inhibitor) level | 54 | $1,037 | $18 |
| Creatinine level to test for kidney function or muscle injury | 105 | $872 | $7 |
| Insertion of needle into vein for collection of blood sample | 155 | $742 | $3 |
| Urine microalbumin (protein) level | 76 | $671 | $8 |
| Blood test, comprehensive group of blood chemicals | 59 | $593 | $9 |
| Hemoglobin a1c level | 36 | $544 | $13 |
| Cyanocobalamin (vitamin b-12) level | 22 | $544 | $20 |
| Magnesium level | 55 | $529 | $9 |
| Folic acid level, serum | 20 | $510 | $20 |
| Red blood cell concentration measurement | 83 | $380 | $3 |
| Blood count, hemoglobin | 82 | $377 | $3 |
| Total protein level, urine | 63 | $354 | $5 |
| Ferritin (blood protein) level | 14 | $346 | $18 |
| Phosphate level | 57 | $294 | $5 |
| Blood test, lipids (cholesterol and triglycerides) | 21 | $261 | $12 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 25 | $250 | $10 |
| Iron binding capacity | 16 | $178 | $9 |
| Iron level | 17 | $173 | $9 |
| Blood test, basic group of blood chemicals (calcium, total) | 13 | $147 | $11 |
| Manual urinalysis test with examination using microscope, automated | 35 | $144 | $4 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 14 | $129 | $9 |
2015: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 130 | $174,834 | $229 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 440 | $85,059 | $59 |
| Return visit (30+ min) | 397 | $52,802 | $80 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 88 | $37,764 | None |
| Hemodialysis procedure with physician evaluation | 168 | $17,626 | $59 |
| New patient visit (45+ min) | 103 | $12,169 | $118 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 34 | $9,620 | $192 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,410 | $165 |
| Complete ultrasound study of arm and leg arteries | 24 | $5,631 | $117 |
| Complete ultrasound scan behind abdominal cavity | 59 | $5,464 | $93 |
| Short return visit (20+ min) | 81 | $3,972 | $47 |
| Injection of drug or substance under skin or into muscle | 88 | $3,065 | $21 |
| Dialysis procedure including 1 evaluation | 11 | $2,733 | $70 |
| Follow-up observation care per day, typically 25 minutes | 14 | $1,181 | $56 |
2014: 15 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 142 | $182,021 | $227 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 462 | $89,643 | $58 |
| Return visit (30+ min) | 399 | $54,822 | $82 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 74 | $27,828 | None |
| Hemodialysis procedure with physician evaluation | 154 | $17,794 | $59 |
| New patient visit (45+ min) | 121 | $15,264 | $126 |
| Home dialysis services per month (20 years or older) | 11 | $12,890 | $187 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 46 | $11,133 | $192 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $8,883 | $162 |
| Short return visit (20+ min) | 86 | $4,653 | $51 |
| Complete ultrasound study of arm and leg arteries | 17 | $3,999 | $118 |
| Complete ultrasound scan behind abdominal cavity | 29 | $2,389 | $82 |
| Injection of drug or substance under skin or into muscle | 74 | $2,257 | $21 |
| Dialysis procedure including 1 evaluation | 17 | $1,961 | $70 |
| Manual urinalysis test with examination using microscope, non-automated | 58 | $237 | $4 |
2013: 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 137 | $196,906 | $224 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 524 | $100,306 | $56 |
| Return visit (30+ min) | 398 | $60,596 | $82 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 65 | $23,150 | None |
| Hemodialysis procedure with physician evaluation | 160 | $16,539 | $57 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 51 | $14,361 | $191 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $10,349 | $157 |
| New patient visit (45+ min) | 77 | $9,587 | $125 |
| Dialysis procedure including 1 evaluation | 19 | $2,684 | $67 |
| Short return visit (20+ min) | 38 | $2,195 | $56 |
| Injection of drug or substance under skin or into muscle | 65 | $2,104 | $22 |
| Manual urinalysis test with examination using microscope, non-automated | 27 | $120 | $4 |
Medicaid work
$37,425 in 2024
Medicaid paid $37,425 for 2,280 billed services this clinician did in 2024, up to 67 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 556 | $26,921 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 61 | $5,047 |
| Return visit (30+ min) | 332 | $4,068 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 746 | $1,285 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 33 | $76 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 22 | $12 |
| COMPREHENSIVE METABOLIC PANEL | 79 | $8 |
| Creatinine; other source | 89 | $7 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 15 | $0 |
| Albumin; urine (eg, microalbumin), quantitative | 60 | $0 |
| Measurement of cystatin C | 55 | $0 |
| Measurement of magnesium | 78 | $0 |
| 2024 | 2,280 | 14 | 67 | $37,425 |
| 2023 | 2,215 | 16 | 51 | $19,849 |
| 2022 | 1,364 | 9 | 44 | $12,631 |
| 2021 | 440 | 3 | 27 | $7,457 |
| 2020 | 915 | 6 | 47 | $9,237 |
| 2019 | 960 | 6 | 38 | $15,317 |
| 2018 | 1,868 | 13 | 61 | $14,711 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 536 | $7,384 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 811 | $5,754 |
| Return visit (30+ min) | 357 | $3,319 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 60 | $1,697 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 32 | $886 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 47 | $377 |
| Long return visit (40+ min) | 14 | $302 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 112 | $79 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 30 | $51 |
| Renal function panel This panel must include the following: Albumin (82040) Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Phosphorus inorganic (phosphate) (84100) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 12 | $0 |
| Albumin; urine (eg, microalbumin), quantitative | 42 | $0 |
| Creatinine; other source | 58 | $0 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 432 | $7,176 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 495 | $2,559 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 92 | $1,936 |
| Return visit (30+ min) | 197 | $576 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 90 | $273 |
| Short return visit (20+ min) | 15 | $112 |
| Creatinine; other source | 13 | $0 |
| Total protein level, urine | 12 | $0 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 18 | $0 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 90 | $3,217 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 175 | $3,075 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 175 | $1,165 |
2020
| Clinic visit/encounter, all-inclusive | 14 | $2,867 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 226 | $2,836 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 462 | $1,652 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 126 | $1,428 |
| Return visit (30+ min) | 57 | $454 |
| Short return visit (20+ min) | 30 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 28 | $6,180 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 380 | $4,901 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 253 | $3,228 |
| Return visit (30+ min) | 92 | $503 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 111 | $454 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 96 | $51 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 598 | $6,761 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 641 | $6,208 |
| Return visit (30+ min) | 262 | $1,021 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 45 | $660 |
| Creatinine; other source | 98 | $60 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 15 | $0 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 39 | $0 |
| Albumin; urine (eg, microalbumin), quantitative | 73 | $0 |
| Measurement of cystatin C | 12 | $0 |
| Parathormone (parathyroid hormone) | 29 | $0 |
| Total protein level, urine | 13 | $0 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 30 | $0 |
Drugs they prescribed that Part D paid
$652,150
Pharmacies billed $652,150 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,441) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
940 generic and 501 brand-name prescriptions · $652,150 in drug cost · 69 antibiotic prescriptions to 55 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Velphoro | 61 | $207,092 | $3,395 |
| Farxiga | 73 | $80,119 | $1,098 |
| Jardiance | 54 | $69,475 | $1,287 |
| Veltassa | 35 | $58,866 | $1,682 |
| Lokelma | 39 | $50,628 | $1,298 |
See all 31 drugs
| Velphoro | 61 | $207,092 | $3,395 |
| Farxiga | 73 | $80,119 | $1,098 |
| Jardiance | 54 | $69,475 | $1,287 |
| Veltassa | 35 | $58,866 | $1,682 |
| Lokelma | 39 | $50,628 | $1,298 |
| Kerendia | 33 | $39,476 | $1,196 |
| Prosol | 134 | $26,487 | $198 |
| Sevelamer Carbonate | 98 | $22,464 | $229 |
| Cinacalcet | 13 | $14,355 | $1,104 |
| Dapagliflozin | 20 | $12,225 | $611 |
| Calcium Acetate | 66 | $5,485 | $83 |
| Nifedipine Er | 21 | $1,437 | $68 |
| Calcitriol | 57 | $1,120 | $20 |
| Tacrolimus | 14 | $1,057 | $75 |
| Losartan | 93 | $730 | $8 |
| Hydralazine | 52 | $692 | $13 |
| Metoprolol | 29 | $660 | $23 |
| Potassium Chloride | 30 | $385 | $13 |
| Tamsulosin | 17 | $335 | $20 |
| Amlodipine Besylate | 50 | $276 | $6 |
| Carvedilol | 20 | $274 | $14 |
| Doxazosin Mesylate | 11 | $272 | $25 |
| Furosemide | 39 | $264 | $7 |
| Lisinopril | 42 | $246 | $6 |
| Lidocaine-Prilocaine | 17 | $244 | $14 |
| Atorvastatin | 20 | $209 | $10 |
| Allopurinol | 21 | $188 | $9 |
| Clonidine | 25 | $184 | $7 |
| Ciprofloxacin | 39 | $103 | $3 |
| Prednisone | 12 | $94 | $8 |
| Hydrochlorothiazide | 18 | $44 | $2 |
Year by year
| 2024 | 1,441 | 392 | 0% (0) | 35% | $652,150 |
| 2023 | 1,294 | 332 | None | 31% | $480,118 |
| 2022 | 1,225 | 308 | 0% (0) | 29% | $437,060 |
| 2021 | 1,265 | 323 | 0% (0) | 23% | $414,066 |
| 2020 | 1,385 | 365 | 0% (0) | 19% | $347,645 |
| 2019 | 1,646 | 388 | 0% (0) | 21% | $351,179 |
| 2018 | 1,961 | 439 | None | None | $509,603 |
| 2017 | 2,040 | 435 | 1% (12) | None | $678,006 |
| 2016 | 2,195 | 428 | 1% (20) | None | $673,374 |
| 2015 | 2,131 | 419 | 1% (12) | 39% | $639,511 |
| 2014 | 2,297 | 440 | 1% (17) | 40% | $587,916 |
| 2013 | 2,473 | 472 | 1% (35) | None | $450,543 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 29 drugs
| Velphoro | 53 | $192,865 | $3,639 |
| Farxiga | 50 | $55,639 | $1,113 |
| Lokelma | 44 | $52,785 | $1,200 |
| Renvela | 18 | $39,713 | $2,206 |
| Prosol | 173 | $29,154 | $169 |
| Veltassa | 27 | $28,946 | $1,072 |
| Sevelamer Carbonate | 90 | $27,747 | $308 |
| Cinacalcet | 18 | $5,389 | $299 |
| Clinisol | 31 | $4,378 | $141 |
| Calcium Acetate | 32 | $2,079 | $65 |
| Potassium Citrate Er | 11 | $1,557 | $142 |
| Losartan | 73 | $1,517 | $21 |
| Amlodipine Besylate | 59 | $1,501 | $25 |
| Hydralazine | 45 | $1,399 | $31 |
| Calcitriol | 46 | $1,294 | $28 |
| Lisinopril | 63 | $1,205 | $19 |
| Carvedilol | 19 | $1,054 | $55 |
| Nifedipine Er | 14 | $748 | $53 |
| Potassium Chloride | 23 | $649 | $28 |
| Metoprolol | 27 | $638 | $24 |
| Clonidine | 17 | $512 | $30 |
| Atorvastatin | 20 | $391 | $20 |
| Doxazosin Mesylate | 17 | $378 | $22 |
| Prednisone | 19 | $342 | $18 |
| Metoprolol | 19 | $278 | $15 |
| Sodium Polystyrene Sulfonate | 11 | $264 | $24 |
| Furosemide | 33 | $208 | $6 |
| Ciprofloxacin | 38 | $162 | $4 |
| Hydrochlorothiazide | 29 | $90 | $3 |
2022: 27 drugs
| Velphoro | 68 | $245,077 | $3,604 |
| Renvela | 12 | $38,626 | $3,219 |
| Sevelamer Carbonate | 105 | $37,259 | $355 |
| Veltassa | 29 | $30,244 | $1,043 |
| Prosol | 179 | $27,092 | $151 |
| Lokelma | 18 | $19,881 | $1,105 |
| Calcium Acetate | 56 | $4,478 | $80 |
| Cinacalcet | 19 | $4,298 | $226 |
| Midodrine | 12 | $3,278 | $273 |
| Calcitriol | 56 | $1,959 | $35 |
| Nifedipine Er | 15 | $1,802 | $120 |
| Hydralazine | 29 | $812 | $28 |
| Amlodipine Besylate | 86 | $796 | $9 |
| Losartan | 42 | $635 | $15 |
| Lisinopril | 52 | $558 | $11 |
| Metoprolol | 20 | $547 | $27 |
| Chlorthalidone | 13 | $411 | $32 |
| Clonidine | 32 | $366 | $11 |
| Potassium Chloride | 11 | $329 | $30 |
| Carvedilol | 21 | $304 | $14 |
| Furosemide | 45 | $302 | $7 |
| Atorvastatin | 33 | $211 | $6 |
| Prednisone | 12 | $210 | $17 |
| Metoprolol | 17 | $199 | $12 |
| Allopurinol | 13 | $131 | $10 |
| Ciprofloxacin | 26 | $82 | $3 |
| Hydrochlorothiazide | 31 | $62 | $2 |
2021: 29 drugs
| Velphoro | 66 | $203,106 | $3,077 |
| Veltassa | 31 | $40,086 | $1,293 |
| Sevelamer Carbonate | 93 | $32,513 | $350 |
| Lokelma | 31 | $24,180 | $780 |
| Cinacalcet | 23 | $13,512 | $587 |
| Prosol | 61 | $12,848 | $211 |
| Calcium Acetate | 76 | $6,711 | $88 |
| Calcitriol | 77 | $2,980 | $39 |
| Midodrine | 13 | $2,015 | $155 |
| Clonidine | 11 | $1,566 | $142 |
| Clinisol | 12 | $1,230 | $102 |
| Hydralazine | 42 | $1,012 | $24 |
| Amlodipine Besylate | 85 | $818 | $10 |
| Lisinopril | 45 | $594 | $13 |
| Losartan | 48 | $574 | $12 |
| Metoprolol | 26 | $560 | $22 |
| Potassium Chloride | 18 | $483 | $27 |
| Furosemide | 72 | $443 | $6 |
| Doxazosin Mesylate | 14 | $430 | $31 |
| Atorvastatin | 32 | $380 | $12 |
| Chlorthalidone | 16 | $368 | $23 |
| Diclofenac | 14 | $250 | $18 |
| Carvedilol | 17 | $193 | $11 |
| Tamsulosin | 15 | $177 | $12 |
| Prednisone | 16 | $170 | $11 |
| Clonidine | 15 | $159 | $11 |
| Hydrochlorothiazide | 35 | $126 | $4 |
| Ciprofloxacin | 22 | $96 | $4 |
| Cephalexin | 15 | $59 | $4 |
2020: 34 drugs
| Velphoro | 51 | $137,066 | $2,688 |
| Renvela | 17 | $44,656 | $2,627 |
| Sevelamer Carbonate | 101 | $34,291 | $340 |
| Veltassa | 13 | $18,049 | $1,388 |
| Cinacalcet | 26 | $17,249 | $663 |
| Lanthanum Carbonate | 18 | $14,637 | $813 |
| Lokelma | 15 | $10,527 | $702 |
| Prosol | 28 | $9,770 | $349 |
| Calcium Acetate | 62 | $4,814 | $78 |
| Clinisol | 31 | $3,828 | $123 |
| Calcitriol | 108 | $3,785 | $35 |
| Ondansetron Odt | 11 | $974 | $89 |
| Losartan | 52 | $954 | $18 |
| Metoprolol | 29 | $917 | $32 |
| Amlodipine Besylate | 109 | $750 | $7 |
| Nifedipine Er | 19 | $711 | $37 |
| Potassium Chloride | 28 | $657 | $23 |
| Hydralazine | 28 | $611 | $22 |
| Chlorthalidone | 22 | $588 | $27 |
| Lisinopril | 62 | $494 | $8 |
| Clonidine | 38 | $481 | $13 |
| Atorvastatin | 32 | $462 | $14 |
| Doxazosin Mesylate | 11 | $443 | $40 |
| Spironolactone | 20 | $350 | $17 |
| Furosemide | 40 | $250 | $6 |
| Carvedilol | 25 | $243 | $10 |
| Prednisone | 17 | $213 | $13 |
| Nitrofurantoin Mono-Macro | 14 | $199 | $14 |
| Allopurinol | 16 | $187 | $12 |
| Pantoprazole | 11 | $182 | $17 |
| Hydrochlorothiazide | 34 | $174 | $5 |
| Metoprolol | 28 | $135 | $5 |
| Ciprofloxacin | 23 | $96 | $4 |
| Cephalexin | 21 | $51 | $2 |
2019: 34 drugs
| Velphoro | 25 | $87,396 | $3,496 |
| Renvela | 34 | $54,006 | $1,588 |
| Sevelamer Carbonate | 110 | $49,937 | $454 |
| Veltassa | 23 | $35,430 | $1,540 |
| Sensipar | 17 | $19,367 | $1,139 |
| Intralipid | 52 | $15,764 | $303 |
| Prosol | 69 | $12,917 | $187 |
| Cinacalcet | 11 | $7,295 | $663 |
| Calcitriol | 183 | $6,667 | $36 |
| Epogen | 11 | $5,234 | $476 |
| Clonidine | 14 | $4,258 | $304 |
| Calcium Acetate | 47 | $3,552 | $76 |
| Metoprolol | 39 | $1,621 | $42 |
| Amlodipine Besylate | 128 | $1,234 | $10 |
| Hydralazine | 51 | $1,210 | $24 |
| Potassium Chloride | 26 | $987 | $38 |
| Travasol | 12 | $941 | $78 |
| Lidocaine-Prilocaine | 22 | $831 | $38 |
| Nifedipine Er | 27 | $816 | $30 |
| Losartan | 66 | $797 | $12 |
| Atorvastatin | 32 | $761 | $24 |
| Lisinopril | 89 | $596 | $7 |
| Chlorthalidone | 15 | $545 | $36 |
| Minoxidil | 18 | $440 | $24 |
| Clonidine | 28 | $408 | $15 |
| Carvedilol | 17 | $371 | $22 |
| Allopurinol | 23 | $291 | $13 |
| Omeprazole | 21 | $261 | $12 |
| Furosemide | 42 | $174 | $4 |
| Metoprolol | 27 | $169 | $6 |
| Prednisone | 14 | $165 | $12 |
| Hydrochlorothiazide | 32 | $129 | $4 |
| Ciprofloxacin | 33 | $121 | $4 |
| Cephalexin | 15 | $82 | $5 |
2018: 38 drugs
| Renvela | 128 | $196,875 | $1,538 |
| Velphoro | 18 | $60,172 | $3,343 |
| Sevelamer Carbonate | 74 | $48,770 | $659 |
| Sensipar | 19 | $27,880 | $1,467 |
| Veltassa | 23 | $25,775 | $1,121 |
| Prosol | 137 | $25,450 | $186 |
| Clinisol | 23 | $12,008 | $522 |
| Intralipid | 32 | $9,695 | $303 |
| Calcitriol | 239 | $8,626 | $36 |
| Calcium Acetate | 79 | $6,038 | $76 |
| Toviaz | 12 | $3,870 | $323 |
| Travasol | 36 | $3,034 | $84 |
| Hydralazine | 82 | $2,206 | $27 |
| Metoprolol | 33 | $1,408 | $43 |
| Amlodipine Besylate | 141 | $1,127 | $8 |
| Nifedipine Er | 25 | $849 | $34 |
| Lisinopril | 114 | $833 | $7 |
| Clonidine | 11 | $796 | $72 |
| Atorvastatin | 39 | $691 | $18 |
| Doxazosin Mesylate | 11 | $618 | $56 |
| Potassium Chloride | 29 | $584 | $20 |
| Losartan | 46 | $440 | $10 |
| Clonidine | 29 | $431 | $15 |
| Omeprazole | 30 | $413 | $14 |
| Pravastatin | 12 | $398 | $33 |
| Allopurinol | 18 | $251 | $14 |
| Losartan-Hydrochlorothiazide | 16 | $238 | $15 |
| Carvedilol | 24 | $213 | $9 |
| Prednisone | 23 | $208 | $9 |
| Spironolactone | 11 | $176 | $16 |
| Metoprolol | 29 | $166 | $6 |
| Hydrochlorothiazide | 28 | $151 | $5 |
| Furosemide | 34 | $135 | $4 |
| Cephalexin | 27 | $131 | $5 |
| Benazepril | 11 | $103 | $9 |
| Ciprofloxacin | 20 | $65 | $3 |
| Dextrose in Water | 15 | $53 | $4 |
| Amoxicillin | 12 | $42 | $3 |
2017: 36 drugs
| Renvela | 181 | $294,536 | $1,627 |
| Sensipar | 88 | $130,330 | $1,481 |
| Prosol | 171 | $38,556 | $225 |
| Velphoro | 12 | $35,060 | $2,922 |
| Clinisol | 63 | $18,609 | $295 |
| Sevelamer Carbonate | 11 | $14,081 | $1,280 |
| Veltassa | 18 | $12,673 | $704 |
| Calcium Acetate | 63 | $5,948 | $94 |
| Calcitriol | 196 | $5,912 | $30 |
| Intralipid | 26 | $5,157 | $198 |
| Toviaz | 12 | $3,531 | $294 |
| Dextrose in Water | 35 | $1,822 | $52 |
| Hydralazine | 89 | $1,666 | $19 |
| Metoprolol | 29 | $1,204 | $42 |
| Nifedipine Er | 18 | $1,135 | $63 |
| Amlodipine Besylate | 155 | $1,100 | $7 |
| Atorvastatin | 40 | $758 | $19 |
| Lisinopril | 92 | $710 | $8 |
| Pravastatin | 19 | $663 | $35 |
| Tamsulosin | 14 | $496 | $35 |
| Carvedilol | 57 | $485 | $9 |
| Losartan | 42 | $354 | $8 |
| Omeprazole | 20 | $344 | $17 |
| Ondansetron | 11 | $335 | $30 |
| Clonidine | 27 | $312 | $12 |
| Pantoprazole | 23 | $302 | $13 |
| Allopurinol | 14 | $261 | $19 |
| Levothyroxine | 12 | $206 | $17 |
| Furosemide | 54 | $193 | $4 |
| Metoprolol | 31 | $191 | $6 |
| Minoxidil | 12 | $162 | $14 |
| Prednisone | 12 | $142 | $12 |
| Ciprofloxacin | 29 | $94 | $3 |
| Cephalexin | 15 | $57 | $4 |
| Hydrochlorothiazide | 13 | $53 | $4 |
| Amoxicillin | 13 | $45 | $3 |
2016: 36 drugs
| Renvela | 193 | $318,828 | $1,652 |
| Sensipar | 81 | $134,659 | $1,662 |
| Prosol | 179 | $67,741 | $378 |
| Fosrenol | 15 | $30,154 | $2,010 |
| Calcium Acetate | 68 | $7,895 | $116 |
| Dextrose in Water | 133 | $6,571 | $49 |
| Clinisol | 51 | $6,405 | $126 |
| Calcitriol | 190 | $5,188 | $27 |
| Humulin 70-30 | 11 | $4,159 | $378 |
| Spiriva | 12 | $4,012 | $334 |
| Clonidine | 16 | $2,545 | $159 |
| Hydralazine | 97 | $2,066 | $21 |
| Valsartan | 18 | $1,423 | $79 |
| Amlodipine Besylate | 179 | $1,182 | $7 |
| Nifedipine Er | 21 | $1,098 | $52 |
| Lisinopril | 116 | $949 | $8 |
| Atorvastatin | 43 | $720 | $17 |
| Metoprolol | 20 | $681 | $34 |
| Clonidine | 32 | $427 | $13 |
| Losartan | 52 | $404 | $8 |
| Carvedilol | 45 | $335 | $7 |
| Pravastatin | 13 | $284 | $22 |
| Omeprazole | 24 | $262 | $11 |
| Allopurinol | 13 | $236 | $18 |
| Minoxidil | 14 | $207 | $15 |
| Pantoprazole | 20 | $201 | $10 |
| Prednisone | 21 | $177 | $8 |
| Benazepril | 14 | $163 | $12 |
| Levothyroxine | 12 | $158 | $13 |
| Furosemide | 35 | $145 | $4 |
| Ciprofloxacin | 33 | $140 | $4 |
| Metoprolol | 22 | $139 | $6 |
| Tramadol | 15 | $109 | $7 |
| Ramipril | 11 | $90 | $8 |
| Hydrochlorothiazide | 16 | $62 | $4 |
| Cephalexin | 12 | $37 | $3 |
2015: 36 drugs
| Renvela | 223 | $321,315 | $1,441 |
| Sensipar | 94 | $125,801 | $1,338 |
| Prosol | 165 | $52,114 | $316 |
| Fosrenol | 25 | $48,679 | $1,947 |
| Nexium | 13 | $6,210 | $478 |
| Calcium Acetate | 46 | $5,400 | $117 |
| Dextrose in Water | 104 | $4,617 | $44 |
| Calcitriol | 145 | $4,574 | $32 |
| Humulin 70-30 | 11 | $3,899 | $354 |
| Clinisol | 30 | $3,452 | $115 |
| Valsartan | 26 | $2,866 | $110 |
| Hydralazine | 75 | $2,056 | $27 |
| Nifedipine Er | 17 | $1,609 | $95 |
| Tamsulosin | 22 | $1,061 | $48 |
| Amlodipine Besylate | 143 | $961 | $7 |
| Lisinopril | 110 | $821 | $7 |
| Clonidine | 64 | $732 | $11 |
| Atorvastatin | 52 | $696 | $13 |
| Allopurinol | 41 | $675 | $16 |
| Minoxidil | 27 | $672 | $25 |
| Doxazosin Mesylate | 16 | $595 | $37 |
| Spironolactone | 23 | $535 | $23 |
| Losartan | 36 | $471 | $13 |
| Potassium Chloride | 14 | $443 | $32 |
| Metoprolol | 12 | $392 | $33 |
| Levothyroxine | 23 | $361 | $16 |
| Carvedilol | 35 | $310 | $9 |
| Omeprazole | 25 | $293 | $12 |
| Metoprolol | 41 | $204 | $5 |
| Pantoprazole | 18 | $190 | $11 |
| Benazepril | 16 | $169 | $11 |
| Hydrochlorothiazide | 30 | $161 | $5 |
| Furosemide | 29 | $145 | $5 |
| Ciprofloxacin | 19 | $115 | $6 |
| Ramipril | 14 | $110 | $8 |
| Lamotrigine | 13 | $106 | $8 |
2014: 39 drugs
| Renvela | 213 | $243,736 | $1,144 |
| Sensipar | 78 | $107,452 | $1,378 |
| Fosrenol | 49 | $74,799 | $1,527 |
| Prosol | 204 | $44,399 | $218 |
| Diovan | 47 | $17,414 | $371 |
| Calcium Acetate | 58 | $7,941 | $137 |
| Calcitriol | 125 | $5,343 | $43 |
| Nifedipine Er | 46 | $3,165 | $69 |
| Dextrose in Water | 51 | $2,168 | $43 |
| Hydralazine | 52 | $1,913 | $37 |
| Amlodipine Besylate | 193 | $1,729 | $9 |
| Lisinopril | 164 | $1,723 | $11 |
| Metoprolol | 12 | $1,252 | $104 |
| Valsartan-Hydrochlorothiazide | 14 | $1,145 | $82 |
| Losartan | 51 | $897 | $18 |
| Clonidine | 64 | $742 | $12 |
| Tamsulosin | 21 | $693 | $33 |
| Atorvastatin | 31 | $652 | $21 |
| Omeprazole | 34 | $629 | $19 |
| Potassium Chloride | 12 | $594 | $50 |
| Spironolactone | 23 | $593 | $26 |
| Doxazosin Mesylate | 14 | $530 | $38 |
| Minoxidil | 16 | $373 | $23 |
| Metoprolol | 56 | $351 | $6 |
| Carvedilol | 18 | $346 | $19 |
| Clotrimazole | 15 | $331 | $22 |
| Allopurinol | 28 | $318 | $11 |
| Levothyroxine | 14 | $269 | $19 |
| Nitrostat | 11 | $259 | $24 |
| Prednisone | 12 | $215 | $18 |
| Hydrochlorothiazide | 39 | $208 | $5 |
| Terazosin | 18 | $144 | $8 |
| Pantoprazole | 16 | $137 | $9 |
| Tramadol | 11 | $120 | $11 |
| Warfarin | 11 | $120 | $11 |
| Gabapentin | 15 | $112 | $7 |
| Furosemide | 28 | $97 | $3 |
| Ciprofloxacin | 25 | $92 | $4 |
| Atenolol | 14 | $90 | $6 |
2013: 40 drugs
| Renvela | 162 | $143,269 | $884 |
| Fosrenol | 46 | $79,878 | $1,736 |
| Prosol | 171 | $55,846 | $327 |
| Sensipar | 42 | $53,435 | $1,272 |
| Diovan | 70 | $21,867 | $312 |
| Calcitriol | 133 | $6,576 | $49 |
| Calcium Acetate | 51 | $5,637 | $111 |
| Nifedipine Er | 52 | $3,482 | $67 |
| Hydralazine | 73 | $2,945 | $40 |
| Amlodipine Besylate | 203 | $2,568 | $13 |
| Lisinopril | 212 | $2,178 | $10 |
| Dextrose in Water | 37 | $1,605 | $43 |
| Lyrica | 13 | $1,530 | $118 |
| Exforge | 12 | $1,477 | $123 |
| Losartan | 61 | $1,294 | $21 |
| Atorvastatin | 34 | $1,251 | $37 |
| Sodium Polystyrene Sulfonate | 13 | $1,194 | $92 |
| Clonidine | 86 | $1,000 | $12 |
| Omeprazole | 26 | $986 | $38 |
| Tamsulosin | 32 | $978 | $31 |
| Potassium Chloride | 21 | $971 | $46 |
| Minoxidil | 28 | $902 | $32 |
| Megestrol Acetate | 26 | $799 | $31 |
| Metolazone | 14 | $755 | $54 |
| Metoprolol | 75 | $602 | $8 |
| Carvedilol | 33 | $565 | $17 |
| Tramadol | 24 | $409 | $17 |
| Hydrochlorothiazide | 58 | $369 | $6 |
| Spironolactone | 26 | $332 | $13 |
| Allopurinol | 34 | $300 | $9 |
| Simvastatin | 25 | $280 | $11 |
| Furosemide | 50 | $277 | $6 |
| Doxazosin Mesylate | 11 | $259 | $24 |
| Warfarin | 16 | $252 | $16 |
| Atenolol | 31 | $251 | $8 |
| Gabapentin | 20 | $226 | $11 |
| Levothyroxine | 18 | $220 | $12 |
| Pantoprazole | 13 | $135 | $10 |
| Ciprofloxacin | 20 | $91 | $5 |
| Cephalexin | 15 | $81 | $5 |
Money from drug and device companies
$157 in 2025
| 2025 | 1 | 10 | None | $157 |
| 2024 | 3 | 6 | None | $130 |
| 2023 | 5 | 9 | None | $164 |
| 2022 | 5 | 8 | None | $129 |
| 2021 | 1 | 1 | None | $12 |
| 2020 | 3 | 3 | None | $49 |
| 2019 | 4 | 9 | None | $139 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Krystexxa | $157 | 10 payments
|
See all 10 published payments
| Amgen | Meals · 2025-12-17 | Tavneos | $14 |
| Amgen | Meals · 2025-11-18 | Krystexxa | $18 |
| Amgen | Meals · 2025-11-17 | Tavneos | $18 |
| Amgen | Meals · 2025-10-14 | Krystexxa | $17 |
| Amgen | Meals · 2025-09-03 | Krystexxa | $5 |
| Amgen | Meals · 2025-08-21 | Tavneos | $17 |
| Amgen | Meals · 2025-07-17 | Krystexxa | $18 |
| Amgen | Meals · 2025-05-21 | Krystexxa | $18 |
| Amgen | Meals · 2025-02-20 | Tavneos | $13 |
| Amgen | Meals · 2025-02-04 | Krystexxa | $18 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $130
| Amgen | Aranesp | $85 | 4 payments
|
| Genzyme | Fabrazyme | $23 | 1 payment
|
| Aurinia Pharma U.S. | Lupkynis | $22 | 1 payment
|
2023: $164
| Horizon Therapeutics plc | Krystexxa | $53 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Evusheld | $37 | 2 payments
|
| GlaxoSmithKline | Benlysta | $37 | 2 payments
|
| Amgen | Aranesp | $23 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $16 | 1 payment
|
2022: $129
| Fresenius USA Marketing | Velphoro | $53 | 4 payments
|
| Otsuka America Pharmaceutical | Jynarque | $24 | 1 payment
|
| Amgen | Parsabiv | $21 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $16 | 1 payment
|
| GlaxoSmithKline | Benlysta | $15 | 1 payment
|
2021: $12
| Horizon Therapeutics plc | Krystexxa | $12 | 1 payment
|
2020: $49
| Argon Medical Devices | Option | $21 | 1 payment
|
| AMAG Pharmaceuticals | Feraheme | $15 | 1 payment
|
| Amgen | Parsabiv | $13 | 1 payment
|
2019: $139
| Shire North American Group | Natpara (Parathyroid Hormone) | $46 | 2 payments
|
| Amgen | Parsabiv | $37 | 3 payments
|
| Novartis Pharmaceuticals | Afinitor | $30 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $25 | 2 payments
|
Professional record
- NPI
- 1669685251
- Licence
- CA A96047California A96047: Current · expires 2028-02-29
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- 568 E Herndon Ave, Suite 201, Fresno, CA, 93720
- NPI first listed
- 2007-05-08
- NPI last updated
- 2017-08-15
This is when the NPI record was last certified, not a medical board exam.